ID   RUVB2_HUMAN             Reviewed;         463 AA.
AC   Q9Y230; B3KQ59; E7ETE5; Q6FIB9; Q6PK27; Q9Y361;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-JAN-2026, entry version 252.
DE   RecName: Full=RuvB-like 2;
DE            EC=3.6.4.12 {ECO:0000269|PubMed:10428817, ECO:0000269|PubMed:17157868};
DE   AltName: Full=48 kDa TATA box-binding protein-interacting protein;
DE            Short=48 kDa TBP-interacting protein;
DE   AltName: Full=51 kDa erythrocyte cytosolic protein;
DE            Short=ECP-51;
DE   AltName: Full=INO80 complex subunit J;
DE   AltName: Full=Repressing pontin 52;
DE            Short=Reptin 52;
DE   AltName: Full=TIP49b;
DE   AltName: Full=TIP60-associated protein 54-beta;
DE            Short=TAP54-beta;
GN   Name=RUVBL2 {ECO:0000312|HGNC:HGNC:10475};
GN   Synonyms=INO80J, TIP48, TIP49B; ORFNames=CGI-46;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 72-83;
RP   131-144; 212-223; 369-372 AND 440-457.
RC   TISSUE=Bone marrow;
RX   PubMed=10524211; DOI=10.1016/s0167-4781(99)00104-9;
RA   Salzer U., Kubicek M., Prohaska R.;
RT   "Isolation, molecular characterization, and tissue-specific expression of
RT   ECP-51 and ECP-54 (TIP49), two homologous, interacting erythroid cytosolic
RT   proteins.";
RL   Biochim. Biophys. Acta 1446:365-370(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RUVBL1, FUNCTION,
RP   CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=10428817; DOI=10.1074/jbc.274.32.22437;
RA   Kanemaki M., Kurokawa Y., Matsu-ura T., Makino Y., Masani A., Okazaki K.,
RA   Morishita T., Tamura T.-A.;
RT   "TIP49b, a new RuvB-like DNA helicase, is included in a complex together
RT   with another RuvB-like DNA helicase, TIP49a.";
RL   J. Biol. Chem. 274:22437-22444(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=10998447; DOI=10.1016/s0003-3995(00)01016-9;
RA   Parfait B., Giovangrandi Y., Asheuer M., Laurendeau I., Olivi M.,
RA   Vodovar N., Vidaud D., Vidaud M., Bieche I.;
RT   "Human TIP49b/RUVBL2 gene: genomic structure, expression pattern, physical
RT   link to the human CGB/LHB gene cluster on chromosome 19q13.3.";
RL   Ann. Genet. 43:69-74(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RX   PubMed=11080158; DOI=10.1093/emboj/19.22.6121;
RA   Bauer A., Chauvet S., Huber O., Usseglio F., Rothbaecher U., Aragnol D.,
RA   Kemler R., Pradel J.;
RT   "Pontin52 and reptin52 function as antagonistic regulators of beta-catenin
RT   signalling activity.";
RL   EMBO J. 19:6121-6130(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 73-83; 116-124;
RP   237-253 AND 254-269, INTERACTION WITH MYC, AND FUNCTION.
RX   PubMed=10882073; DOI=10.1016/s1097-2765(00)80427-x;
RA   Wood M.A., McMahon S.B., Cole M.D.;
RT   "An ATPase/helicase complex is an essential cofactor for oncogenic
RT   transformation by c-Myc.";
RL   Mol. Cell 5:321-330(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Embryo, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-14.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [14]
RP   PROTEIN SEQUENCE OF 2-18; 30-53; 55-64; 72-83; 116-124; 165-177; 237-269;
RP   335-368; 393-400 AND 418-438, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION
RP   AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [15]
RP   PROTEIN SEQUENCE OF 30-40; 185-197; 354-365 AND 417-427, IDENTIFICATION IN
RP   THE NUA4 COMPLEX, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=10966108; DOI=10.1016/s0092-8674(00)00051-9;
RA   Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M.,
RA   Scully R., Qin J., Nakatani Y.;
RT   "Involvement of the TIP60 histone acetylase complex in DNA repair and
RT   apoptosis.";
RL   Cell 102:463-473(2000).
RN   [16]
RP   PROTEIN SEQUENCE OF 30-40; 72-83; 165-177; 187-197; 254-269; 354-365;
RP   418-438 AND 445-463, IDENTIFICATION IN NUA4 COMPLEX, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=12963728; DOI=10.1074/jbc.c300389200;
RA   Cai Y., Jin J., Tomomori-Sato C., Sato S., Sorokina I., Parmely T.J.,
RA   Conaway R.C., Conaway J.W.;
RT   "Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-
RT   containing histone acetyltransferase complex.";
RL   J. Biol. Chem. 278:42733-42736(2003).
RN   [17]
RP   INTERACTION WITH ATF2, AND FUNCTION.
RX   PubMed=11713276; DOI=10.1128/mcb.21.24.8398-8413.2001;
RA   Cho S.-G., Bhoumik A., Broday L., Ivanov V., Rosenstein B., Ronai Z.;
RT   "TIP49b, a regulator of activating transcription factor 2 response to
RT   stress and DNA damage.";
RL   Mol. Cell. Biol. 21:8398-8413(2001).
RN   [18]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN NUA4
RP   COMPLEX, AND IDENTIFICATION IN A NUA4-RELATED SRCAP-CONTAINING COMPLEX.
RX   PubMed=14966270; DOI=10.1128/mcb.24.5.1884-1896.2004;
RA   Doyon Y., Selleck W., Lane W.S., Tan S., Cote J.;
RT   "Structural and functional conservation of the NuA4 histone
RT   acetyltransferase complex from yeast to humans.";
RL   Mol. Cell. Biol. 24:1884-1896(2004).
RN   [19]
RP   IDENTIFICATION IN THE MLL1/MLL COMPLEX.
RX   PubMed=15960975; DOI=10.1016/j.cell.2005.04.031;
RA   Dou Y., Milne T.A., Tackett A.J., Smith E.R., Fukuda A., Wysocka J.,
RA   Allis C.D., Chait B.T., Hess J.L., Roeder R.G.;
RT   "Physical association and coordinate function of the H3 K4
RT   methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.";
RL   Cell 121:873-885(2005).
RN   [20]
RP   IDENTIFICATION IN INO80 COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   FUNCTION.
RX   PubMed=16230350; DOI=10.1074/jbc.m509128200;
RA   Jin J., Cai Y., Yao T., Gottschalk A.J., Florens L., Swanson S.K.,
RA   Gutierrez J.L., Coleman M.K., Workman J.L., Mushegian A., Washburn M.P.,
RA   Conaway R.C., Conaway J.W.;
RT   "A mammalian chromatin remodeling complex with similarities to the yeast
RT   INO80 complex.";
RL   J. Biol. Chem. 280:41207-41212(2005).
RN   [21]
RP   INTERACTION WITH HINT1, AND FUNCTION.
RX   PubMed=16014379; DOI=10.1242/jcs.02437;
RA   Weiske J., Huber O.;
RT   "The histidine triad protein Hint1 interacts with Pontin and Reptin and
RT   inhibits TCF-beta-catenin-mediated transcription.";
RL   J. Cell Sci. 118:3117-3129(2005).
RN   [22]
RP   SUBUNIT, FUNCTION, MUTAGENESIS OF ASP-299, AND ELECTRON MICROSCOPY OF THE
RP   RUVBL1-RUVBL2 HETEROMER.
RX   PubMed=17157868; DOI=10.1016/j.jmb.2006.11.030;
RA   Puri T., Wendler P., Sigala B., Saibil H., Tsaneva I.R.;
RT   "Dodecameric structure and ATPase activity of the human TIP48/TIP49
RT   complex.";
RL   J. Mol. Biol. 366:179-192(2007).
RN   [23]
RP   IDENTIFICATION IN THE INO80 COMPLEX, AND PROTEIN INTERACTION.
RX   PubMed=18026119; DOI=10.1038/nsmb1332;
RA   Wu S., Shi Y., Mulligan P., Gay F., Landry J., Liu H., Lu J., Qi H.H.,
RA   Wang W., Nickoloff J.A., Wu C., Shi Y.;
RT   "A YY1-INO80 complex regulates genomic stability through homologous
RT   recombination-based repair.";
RL   Nat. Struct. Mol. Biol. 14:1165-1172(2007).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH NPAT.
RX   PubMed=17967892; DOI=10.1128/mcb.00607-07;
RA   DeRan M., Pulvino M., Greene E., Su C., Zhao J.;
RT   "Transcriptional activation of histone genes requires NPAT-dependent
RT   recruitment of TRRAP-Tip60 complex to histone promoters during the G1/S
RT   phase transition.";
RL   Mol. Cell. Biol. 28:435-447(2008).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [26]
RP   INTERACTION WITH IGHMBP2.
RX   PubMed=19299493; DOI=10.1093/hmg/ddp134;
RA   de Planell-Saguer M., Schroeder D.G., Rodicio M.C., Cox G.A.,
RA   Mourelatos Z.;
RT   "Biochemical and genetic evidence for a role of IGHMBP2 in the
RT   translational machinery.";
RL   Hum. Mol. Genet. 18:2115-2126(2009).
RN   [27]
RP   INTERACTION WITH APPL1 AND APPL2.
RX   PubMed=19433865; DOI=10.1074/jbc.m109.007237;
RA   Rashid S., Pilecka I., Torun A., Olchowik M., Bielinska B., Miaczynska M.;
RT   "Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-
RT   catenin/TCF-mediated transcription.";
RL   J. Biol. Chem. 284:18115-18128(2009).
RN   [28]
RP   INTERACTION WITH TELO2.
RX   PubMed=20801936; DOI=10.1101/gad.1956410;
RA   Takai H., Xie Y., de Lange T., Pavletich N.P.;
RT   "Tel2 structure and function in the Hsp90-dependent maturation of mTOR and
RT   ATR complexes.";
RL   Genes Dev. 24:2019-2030(2010).
RN   [29]
RP   IDENTIFICATION IN THE R2TP COMPLEX.
RX   PubMed=20864032; DOI=10.1016/j.molcel.2010.08.037;
RA   Horejsi Z., Takai H., Adelman C.A., Collis S.J., Flynn H., Maslen S.,
RA   Skehel J.M., de Lange T., Boulton S.J.;
RT   "CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for
RT   mTOR and SMG1 stability.";
RL   Mol. Cell 39:839-850(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   IDENTIFICATION IN THE INO80 COMPLEX, AND FUNCTION.
RX   PubMed=21303910; DOI=10.1074/jbc.m111.222505;
RA   Chen L., Cai Y., Jin J., Florens L., Swanson S.K., Washburn M.P.,
RA   Conaway J.W., Conaway R.C.;
RT   "Subunit organization of the human INO80 chromatin remodeling complex: An
RT   evolutionarily conserved core complex catalyzes ATP-dependent nucleosome
RT   remodeling.";
RL   J. Biol. Chem. 286:11283-11289(2011).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [34]
RP   INTERACTION WITH ITFG1.
RX   PubMed=25437307; DOI=10.7554/elife.04449;
RA   Kato M., Chou T.F., Yu C.Z., DeModena J., Sternberg P.W.;
RT   "LINKIN, a new transmembrane protein necessary for cell adhesion.";
RL   Elife 3:E04449-E04449(2014).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   FUNCTION, AND IDENTIFICATION IN THE SWR1-LIKE COMPLEX.
RX   PubMed=24463511; DOI=10.1038/nature12922;
RA   Obri A., Ouararhni K., Papin C., Diebold M.L., Padmanabhan K., Marek M.,
RA   Stoll I., Roy L., Reilly P.T., Mak T.W., Dimitrov S., Romier C.,
RA   Hamiche A.;
RT   "ANP32E is a histone chaperone that removes H2A.Z from chromatin.";
RL   Nature 505:648-653(2014).
RN   [37]
RP   FUNCTION.
RX   PubMed=25652260; DOI=10.15252/embr.201439123;
RA   Marza E., Taouji S., Barroso K., Raymond A.A., Guignard L., Bonneu M.,
RA   Pallares-Lupon N., Dupuy J.W., Fernandez-Zapico M.E., Rosenbaum J.,
RA   Palladino F., Dupuy D., Chevet E.;
RT   "Genome-wide screen identifies a novel p97/CDC-48-dependent pathway
RT   regulating ER-stress-induced gene transcription.";
RL   EMBO Rep. 16:332-340(2015).
RN   [38]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [39]
RP   INTERACTION WITH WAC.
RX   PubMed=26812014; DOI=10.1016/j.devcel.2015.12.019;
RA   David-Morrison G., Xu Z., Rui Y.N., Charng W.L., Jaiswal M., Yamamoto S.,
RA   Xiong B., Zhang K., Sandoval H., Duraine L., Zuo Z., Zhang S., Bellen H.J.;
RT   "WAC regulates mTOR activity by acting as an adaptor for the TTT and
RT   Pontin/Reptin complexes.";
RL   Dev. Cell 36:139-151(2016).
RN   [40]
RP   FUNCTION, AND INTERACTION WITH ZNHIT1; ZNHIT2; ZNHIT3; ZNHIT6 AND DDX59.
RX   PubMed=28561026; DOI=10.1038/ncomms15615;
RA   Cloutier P., Poitras C., Durand M., Hekmat O., Fiola-Masson E.,
RA   Bouchard A., Faubert D., Chabot B., Coulombe B.;
RT   "R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2
RT   to regulate assembly of U5 small nuclear ribonucleoprotein.";
RL   Nat. Commun. 8:15615-15615(2017).
RN   [41]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-9; LYS-444 AND LYS-456, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [42]
RP   INTERACTION WITH ZMYND10.
RX   PubMed=29601588; DOI=10.1371/journal.pgen.1007316;
RA   Cho K.J., Noh S.H., Han S.M., Choi W.I., Kim H.Y., Yu S., Lee J.S.,
RA   Rim J.H., Lee M.G., Hildebrandt F., Gee H.Y.;
RT   "ZMYND10 stabilizes intermediate chain proteins in the cytoplasmic pre-
RT   assembly of dynein arms.";
RL   PLoS Genet. 14:E1007316-E1007316(2018).
RN   [43]
RP   INTERACTION WITH MUMPS VIRUS L POLYMERASE (MICROBIAL INFECTION).
RX   PubMed=31121004; DOI=10.1371/journal.ppat.1007749;
RA   Katoh H., Sekizuka T., Nakatsu Y., Nakagawa R., Nao N., Sakata M., Kato F.,
RA   Kuroda M., Kidokoro M., Takeda M.;
RT   "The R2TP complex regulates paramyxovirus RNA synthesis.";
RL   PLoS Pathog. 15:e1007749-e1007749(2019).
RN   [44]
RP   IDENTIFICATION IN THE PAQOSOME COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=31738558; DOI=10.1021/acs.jproteome.9b00599;
RA   Cloutier P., Poitras C., Faubert D., Bouchard A., Blanchette M.,
RA   Gauthier M.S., Coulombe B.;
RT   "Upstream ORF-Encoded ASDURF Is a Novel Prefoldin-like Subunit of the
RT   PAQosome.";
RL   J. Proteome Res. 19:18-27(2020).
RN   [45]
RP   INTERACTION WITH NOPCHAP1, AND MUTAGENESIS OF LYS-83 AND GLU-300.
RX   PubMed=33367824; DOI=10.1093/nar/gkaa1226;
RA   Abel Y., Paiva A.C.F., Bizarro J., Chagot M.E., Santo P.E., Robert M.C.,
RA   Quinternet M., Vandermoere F., Sousa P.M.F., Fort P., Charpentier B.,
RA   Manival X., Bandeiras T.M., Bertrand E., Verheggen C.;
RT   "NOPCHAP1 is a PAQosome cofactor that helps loading NOP58 on RUVBL1/2
RT   during box C/D snoRNP biogenesis.";
RL   Nucleic Acids Res. 49:1094-1113(2021).
RN   [46]
RP   STRUCTURE BY NMR OF 132-213.
RG   Mycobacterium tuberculosis structural genomics consortium (TB);
RT   "Solution structure of RSGI RUH-039, a fragment of C-terminal domain of
RT   RuvB-like 2 from human cDNA.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [47] {ECO:0007744|PDB:6IGM}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.00 ANGSTROMS) AS PART OF SRCAP COMPLEX,
RP   AND IDENTIFICATION IN THE SRCAP COMPLEX.
RX   PubMed=30337683; DOI=10.1038/s41422-018-0102-y;
RA   Feng Y., Tian Y., Wu Z., Xu Y.;
RT   "Cryo-EM structure of human SRCAP complex.";
RL   Cell Res. 28:1121-1123(2018).
RN   [48] {ECO:0007744|PDB:7AHO}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.18 ANGSTROMS) IN COMPLEX WITH RUVBL1,
RP   SUBUNIT, INTERACTION WITH SMG1 AND DHX34, AND MUTAGENESIS OF GLU-300.
RX   PubMed=33205750; DOI=10.7554/elife.63042;
RA   Lopez-Perrote A., Hug N., Gonzalez-Corpas A., Rodriguez C.F., Serna M.,
RA   Garcia-Martin C., Boskovic J., Fernandez-Leiro R., Caceres J.F., Llorca O.;
RT   "Regulation of RUVBL1-RUVBL2 AAA-ATPases by the nonsense-mediated mRNA
RT   decay factor DHX34, as evidenced by Cryo-EM.";
RL   Elife 9:0-0(2020).
CC   -!- FUNCTION: Possesses single-stranded DNA-stimulated ATPase and ATP-
CC       dependent DNA helicase (5' to 3') activity; hexamerization is thought
CC       to be critical for ATP hydrolysis and adjacent subunits in the ring-
CC       like structure contribute to the ATPase activity (PubMed:10428817,
CC       PubMed:17157868, PubMed:33205750). Component of the NuA4 histone
CC       acetyltransferase complex which is involved in transcriptional
CC       activation of select genes principally by acetylation of nucleosomal
CC       histones H4 and H2A (PubMed:14966270). This modification may both alter
CC       nucleosome -DNA interactions and promote interaction of the modified
CC       histones with other proteins which positively regulate transcription
CC       (PubMed:14966270). This complex may be required for the activation of
CC       transcriptional programs associated with oncogene and proto-oncogene
CC       mediated growth induction, tumor suppressor mediated growth arrest and
CC       replicative senescence, apoptosis, and DNA repair (PubMed:14966270).
CC       The NuA4 complex ATPase and helicase activities seem to be, at least in
CC       part, contributed by the association of RUVBL1 and RUVBL2 with EP400
CC       (PubMed:14966270). NuA4 may also play a direct role in DNA repair when
CC       recruited to sites of DNA damage (PubMed:14966270). Component of a
CC       SWR1-like complex that specifically mediates the removal of histone
CC       H2A.Z/H2AZ1 from the nucleosome (PubMed:24463511). Proposed core
CC       component of the chromatin remodeling INO80 complex which exhibits
CC       DNA- and nucleosome-activated ATPase activity and catalyzes ATP-
CC       dependent nucleosome sliding (PubMed:16230350, PubMed:21303910). Plays
CC       an essential role in oncogenic transformation by MYC and also modulates
CC       transcriptional activation by the LEF1/TCF1-CTNNB1 complex
CC       (PubMed:10882073, PubMed:16014379). May also inhibit the
CC       transcriptional activity of ATF2 (PubMed:11713276). Involved in the
CC       endoplasmic reticulum (ER)-associated degradation (ERAD) pathway where
CC       it negatively regulates expression of ER stress response genes
CC       (PubMed:25652260). May play a role in regulating the composition of the
CC       U5 snRNP complex (PubMed:28561026). {ECO:0000269|PubMed:10428817,
CC       ECO:0000269|PubMed:10882073, ECO:0000269|PubMed:11713276,
CC       ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:16014379,
CC       ECO:0000269|PubMed:16230350, ECO:0000269|PubMed:17157868,
CC       ECO:0000269|PubMed:21303910, ECO:0000269|PubMed:24463511,
CC       ECO:0000269|PubMed:25652260, ECO:0000269|PubMed:28561026,
CC       ECO:0000269|PubMed:33205750}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC         Evidence={ECO:0000269|PubMed:10428817, ECO:0000269|PubMed:17157868};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13066;
CC         Evidence={ECO:0000305|PubMed:10428817};
CC   -!- SUBUNIT: Forms homohexameric rings (PubMed:33205750). Can form a
CC       dodecamer with RUVBL1 made of two stacked hexameric rings; however,
CC       even though RUVBL1 and RUVBL2 are present in equimolar ratio, the
CC       oligomeric status of each hexamer is not known (PubMed:33205750).
CC       Oligomerization may regulate binding to nucleic acids and conversely,
CC       binding to nucleic acids may affect the dodecameric assembly.
CC       Interaction of the complex with DHX34 results in conformational changes
CC       of the N-terminus of the RUVBL2 subunits, resulting in loss of
CC       nucleotide binding ability and ATP hydrolysis of the complex
CC       (PubMed:33205750). Interacts with the transcriptional activation domain
CC       of MYC. Interacts with ATF2. Component of the RNA polymerase II
CC       holoenzyme complex. May also act to bridge the LEF1/TCF1-CTNNB1 complex
CC       and TBP. Component of the NuA4 histone acetyltransferase complex which
CC       contains the catalytic subunit KAT5/TIP60 and the subunits EP400,
CC       TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2,
CC       ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP,
CC       YEATS4/GAS41, VPS72/YL1 and MEAF6. The NuA4 complex interacts with MYC
CC       and the adenovirus E1A protein. RUVBL2 interacts with EP400. Component
CC       of a NuA4-related complex which contains EP400, TRRAP/PAF400, SRCAP,
CC       BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, actin,
CC       ACTL6A/BAF53A, VPS72 and YEATS4/GAS41. Interacts with NPAT. Component
CC       of the chromatin-remodeling INO80 complex; specifically part of a
CC       complex module associated with the helicase ATP-binding and the
CC       helicase C-terminal domain of INO80. Component of some MLL1/MLL
CC       complex, at least composed of the core components KMT2A/MLL1, ASH2L,
CC       HCFC1/HCF1, WDR5 and RBBP5, as well as the facultative components
CC       BACC1, CHD8, E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA,
CC       MYST1/MOF, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B,
CC       SENP3, TAF1, TAF4, TAF6, TAF7, TAF9 and TEX10. Interacts with IGHMBP2.
CC       Interacts with TELO2. Interacts with HINT1. Component of a SWR1-like
CC       complex. Component of the R2TP complex composed at least of RUVBL1,
CC       RUVBL2, RPAP3 and PIHD1 (PubMed:20864032). Component of the PAQosome
CC       complex which is responsible for the biogenesis of several protein
CC       complexes and which consists of R2TP complex members RUVBL1, RUVBL2,
CC       RPAP3 and PIH1D1, URI complex members PFDN2, PFDN6, PDRG1, UXT and URI1
CC       as well as ASDURF, POLR2E and DNAAF10/WDR92 (PubMed:31738558).
CC       Interacts with ITFG1 (PubMed:25437307). Interacts with ZMYND10
CC       (PubMed:29601588). Interacts with WAC; WAC positively regulates MTOR
CC       activity by promoting the assembly of the TTT complex composed of
CC       TELO2, TTI1 and TTI2 and the RUVBL complex composed of RUVBL1 and
CC       RUVBL2 into the TTT-RUVBL complex which leads to the dimerization of
CC       the mTORC1 complex and its subsequent activation (PubMed:26812014).
CC       Forms a complex with APPL1 and APPL2 (PubMed:19433865). Interacts with
CC       ZNHIT2 (via HIT-type zinc finger) in the presence of ATP or ADP; shows
CC       a stronger interaction in the presence of ADP (PubMed:28561026). The
CC       RUVBL1/RUVBL2 complex interacts with ZNHIT1 (via HIT-type zinc finger),
CC       ZNHIT3 (via HIT-type zinc finger), ZNHIT6 (via HIT-type zinc finger)
CC       and DDX59/ZNHIT5 (via HIT-type zinc finger) in the presence of ADP
CC       (PubMed:28561026). Interacts with NOPCHAP1; the interaction is direct
CC       and disrupted upon ATP binding (PubMed:33367824). Interacts with SMG1
CC       (PubMed:33205750). {ECO:0000269|PubMed:10428817,
CC       ECO:0000269|PubMed:10882073, ECO:0000269|PubMed:10966108,
CC       ECO:0000269|PubMed:11713276, ECO:0000269|PubMed:12963728,
CC       ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:15960975,
CC       ECO:0000269|PubMed:16014379, ECO:0000269|PubMed:16230350,
CC       ECO:0000269|PubMed:17157868, ECO:0000269|PubMed:17967892,
CC       ECO:0000269|PubMed:18026119, ECO:0000269|PubMed:19299493,
CC       ECO:0000269|PubMed:19433865, ECO:0000269|PubMed:20801936,
CC       ECO:0000269|PubMed:20864032, ECO:0000269|PubMed:21303910,
CC       ECO:0000269|PubMed:24463511, ECO:0000269|PubMed:25437307,
CC       ECO:0000269|PubMed:26812014, ECO:0000269|PubMed:28561026,
CC       ECO:0000269|PubMed:29601588, ECO:0000269|PubMed:31738558,
CC       ECO:0000269|PubMed:33205750, ECO:0000269|PubMed:33367824, ECO:0000305}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Mumps L polymerase; this
CC       interaction regulates the viral transcription.
CC       {ECO:0000269|PubMed:31121004}.
CC   -!- SUBCELLULAR LOCATION: Nucleus matrix. Nucleus, nucleoplasm. Cytoplasm.
CC       Membrane. Dynein axonemal particle {ECO:0000250|UniProtKB:Q9DE27}.
CC       Note=Mainly localized in the nucleus, associated with nuclear matrix or
CC       in the nuclear cytosol. Although it is also present in the cytoplasm
CC       and associated with the cell membranes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y230-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y230-2; Sequence=VSP_056584;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Highly expressed in testis
CC       and thymus. {ECO:0000269|PubMed:10428817}.
CC   -!- DOMAIN: The C-terminal domain is required for association with ATF2.
CC   -!- SIMILARITY: Belongs to the RuvB family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD34041.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH08355.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/42185/RUVBL2";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y18417; CAB46270.1; -; mRNA.
DR   EMBL; AB024301; BAA76708.1; -; mRNA.
DR   EMBL; AF155138; AAD38073.1; -; mRNA.
DR   EMBL; AF124607; AAF87087.1; -; mRNA.
DR   EMBL; AF151804; AAD34041.1; ALT_FRAME; mRNA.
DR   EMBL; AL136743; CAB66677.1; -; mRNA.
DR   EMBL; AK057498; BAG51921.1; -; mRNA.
DR   EMBL; AK074542; BAC11048.1; -; mRNA.
DR   EMBL; CR533507; CAG38538.1; -; mRNA.
DR   EMBL; AC008687; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471177; EAW52426.1; -; Genomic_DNA.
DR   EMBL; CH471177; EAW52430.1; -; Genomic_DNA.
DR   EMBL; BC000428; AAH00428.1; -; mRNA.
DR   EMBL; BC004531; AAH04531.1; -; mRNA.
DR   EMBL; BC008355; AAH08355.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS42588.1; -. [Q9Y230-1]
DR   PIR; T46313; T46313.
DR   RefSeq; NP_001308120.1; NM_001321191.1. [Q9Y230-2]
DR   RefSeq; NP_006657.1; NM_006666.3. [Q9Y230-1]
DR   PDB; 2CQA; NMR; -; A=132-213.
DR   PDB; 2XSZ; X-ray; 3.00 A; D/E/F=2-133, D/E/F=238-463.
DR   PDB; 3UK6; X-ray; 2.95 A; A/B/C/D/E/F/G/H/I/J/K/L=1-132, A/B/C/D/E/F/G/H/I/J/K/L=239-463.
DR   PDB; 5OAF; EM; 4.06 A; B/D/F=1-463.
DR   PDB; 6FO1; EM; 3.57 A; D/E/F=1-463.
DR   PDB; 6H7X; X-ray; 2.89 A; A=1-463.
DR   PDB; 6HTS; EM; 4.80 A; B/D/F=1-463.
DR   PDB; 6IGM; EM; 4.00 A; B/D/F=1-463.
DR   PDB; 6K0R; X-ray; 2.50 A; D/E/F/J/K/L=1-133, D/E/F/J/K/L=238-463.
DR   PDB; 6QI8; EM; 3.75 A; D/E/F=1-463.
DR   PDB; 6QI9; EM; 4.63 A; D/E/F=1-463.
DR   PDB; 7AHO; EM; 4.18 A; D/E/F=1-463.
DR   PDB; 7OLE; EM; 3.41 A; B/D/F=1-463.
DR   PDB; 7P6X; EM; 4.10 A; D/E/F=1-463.
DR   PDB; 7ZI4; EM; 3.20 A; B/D/F=1-463.
DR   PDB; 8QR1; EM; 2.40 A; D/H/J=1-463.
DR   PDB; 8X15; EM; 3.20 A; N/P/R=1-463.
DR   PDB; 8X19; EM; 3.20 A; N/P/R=1-463.
DR   PDB; 8X1C; EM; 3.20 A; N/P/R=1-463.
DR   PDB; 8XVG; EM; 9.40 A; B/D/F=1-463.
DR   PDB; 8XVT; EM; 3.20 A; B/D/F=1-463.
DR   PDB; 9C57; EM; 2.75 A; B/D/F=1-463.
DR   PDB; 9C62; EM; 5.28 A; B/D/F=1-463.
DR   PDB; 9CA7; EM; 3.35 A; F/H/J=1-463.
DR   PDB; 9CA8; EM; 3.92 A; F/H/J=1-463.
DR   PDB; 9CA9; EM; 3.56 A; F/H/J=1-463.
DR   PDB; 9CAA; EM; 4.04 A; F/H/J=1-463.
DR   PDB; 9CAB; EM; 3.94 A; F/H/J=1-463.
DR   PDB; 9CAC; EM; 3.43 A; F/H/J=1-463.
DR   PDB; 9CAE; EM; 3.07 A; F/H/J=1-463.
DR   PDB; 9EMA; EM; 2.40 A; D/E/F=1-463.
DR   PDB; 9EMC; EM; 3.26 A; D/E/F=1-463.
DR   PDB; 9GCG; EM; 3.43 A; D/E/F=1-463.
DR   PDB; 9GE5; EM; 3.35 A; D/E/F=15-453.
DR   PDB; 9GEV; EM; 3.47 A; D/E/F=1-463.
DR   PDB; 9GFB; EM; 3.55 A; D/E/F=1-463.
DR   PDBsum; 2CQA; -.
DR   PDBsum; 2XSZ; -.
DR   PDBsum; 3UK6; -.
DR   PDBsum; 5OAF; -.
DR   PDBsum; 6FO1; -.
DR   PDBsum; 6H7X; -.
DR   PDBsum; 6HTS; -.
DR   PDBsum; 6IGM; -.
DR   PDBsum; 6K0R; -.
DR   PDBsum; 6QI8; -.
DR   PDBsum; 6QI9; -.
DR   PDBsum; 7AHO; -.
DR   PDBsum; 7OLE; -.
DR   PDBsum; 7P6X; -.
DR   PDBsum; 7ZI4; -.
DR   PDBsum; 8QR1; -.
DR   PDBsum; 8X15; -.
DR   PDBsum; 8X19; -.
DR   PDBsum; 8X1C; -.
DR   PDBsum; 8XVG; -.
DR   PDBsum; 8XVT; -.
DR   PDBsum; 9C57; -.
DR   PDBsum; 9C62; -.
DR   PDBsum; 9CA7; -.
DR   PDBsum; 9CA8; -.
DR   PDBsum; 9CA9; -.
DR   PDBsum; 9CAA; -.
DR   PDBsum; 9CAB; -.
DR   PDBsum; 9CAC; -.
DR   PDBsum; 9CAE; -.
DR   PDBsum; 9EMA; -.
DR   PDBsum; 9EMC; -.
DR   PDBsum; 9GCG; -.
DR   PDBsum; 9GE5; -.
DR   PDBsum; 9GEV; -.
DR   PDBsum; 9GFB; -.
DR   AlphaFoldDB; Q9Y230; -.
DR   EMDB; EMD-11789; -.
DR   EMDB; EMD-12979; -.
DR   EMDB; EMD-13233; -.
DR   EMDB; EMD-14737; -.
DR   EMDB; EMD-18581; -.
DR   EMDB; EMD-18591; -.
DR   EMDB; EMD-18597; -.
DR   EMDB; EMD-18598; -.
DR   EMDB; EMD-18611; -.
DR   EMDB; EMD-18794; -.
DR   EMDB; EMD-19815; -.
DR   EMDB; EMD-19817; -.
DR   EMDB; EMD-3773; -.
DR   EMDB; EMD-37984; -.
DR   EMDB; EMD-37988; -.
DR   EMDB; EMD-37990; -.
DR   EMDB; EMD-38703; -.
DR   EMDB; EMD-38718; -.
DR   EMDB; EMD-3954; -.
DR   EMDB; EMD-4287; -.
DR   EMDB; EMD-4289; -.
DR   EMDB; EMD-4290; -.
DR   EMDB; EMD-4291; -.
DR   EMDB; EMD-45206; -.
DR   EMDB; EMD-45240; -.
DR   EMDB; EMD-45381; -.
DR   EMDB; EMD-45382; -.
DR   EMDB; EMD-45383; -.
DR   EMDB; EMD-45384; -.
DR   EMDB; EMD-45385; -.
DR   EMDB; EMD-45386; -.
DR   EMDB; EMD-45388; -.
DR   EMDB; EMD-4552; -.
DR   EMDB; EMD-4553; -.
DR   EMDB; EMD-4554; -.
DR   EMDB; EMD-4555; -.
DR   EMDB; EMD-4556; -.
DR   EMDB; EMD-4557; -.
DR   EMDB; EMD-51229; -.
DR   EMDB; EMD-51290; -.
DR   EMDB; EMD-51307; -.
DR   EMDB; EMD-51312; -.
DR   EMDB; EMD-9668; -.
DR   SASBDB; Q9Y230; -.
DR   SMR; Q9Y230; -.
DR   BioGRID; 116067; 652.
DR   ComplexPortal; CPX-6143; R2TP core co-chaperone complex.
DR   ComplexPortal; CPX-6150; R2SP co-chaperone complex.
DR   ComplexPortal; CPX-6152; R2SD co-chaperone complex.
DR   ComplexPortal; CPX-6153; R2T co-chaperone complex.
DR   ComplexPortal; CPX-846; INO80 chromatin remodeling complex.
DR   ComplexPortal; CPX-974; SRCAP chromatin remodeling complex.
DR   ComplexPortal; CPX-978; NuA4 histone acetyltransferase complex.
DR   CORUM; Q9Y230; -.
DR   DIP; DIP-28153N; -.
DR   FunCoup; Q9Y230; 3047.
DR   MINT; Q9Y230; -.
DR   STRING; 9606.ENSP00000473172; -.
DR   BindingDB; Q9Y230; -.
DR   ChEMBL; CHEMBL2062349; -.
DR   DrugBank; DB04216; Quercetin.
DR   GlyGen; Q9Y230; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q9Y230; -.
DR   MetOSite; Q9Y230; -.
DR   PhosphoSitePlus; Q9Y230; -.
DR   SwissPalm; Q9Y230; -.
DR   BioMuta; RUVBL2; -.
DR   DMDM; 28201890; -.
DR   REPRODUCTION-2DPAGE; IPI00009104; -.
DR   CPTAC; CPTAC-270; -.
DR   CPTAC; CPTAC-271; -.
DR   jPOST; Q9Y230; -.
DR   MassIVE; Q9Y230; -.
DR   PaxDb; 9606-ENSP00000473172; -.
DR   PeptideAtlas; Q9Y230; -.
DR   ProteomicsDB; 3549; -.
DR   ProteomicsDB; 85619; -. [Q9Y230-1]
DR   Pumba; Q9Y230; -.
DR   Antibodypedia; 3244; 431 antibodies from 37 providers.
DR   DNASU; 10856; -.
DR   Ensembl; ENST00000595090.6; ENSP00000473172.1; ENSG00000183207.16. [Q9Y230-1]
DR   GeneID; 10856; -.
DR   KEGG; hsa:10856; -.
DR   MANE-Select; ENST00000595090.6; ENSP00000473172.1; NM_006666.3; NP_006657.1.
DR   UCSC; uc002plr.2; human. [Q9Y230-1]
DR   AGR; HGNC:10475; -.
DR   ClinPGx; PA34888; -.
DR   CTD; 10856; -.
DR   DisGeNET; 10856; -.
DR   GeneCards; RUVBL2; -.
DR   HGNC; HGNC:10475; RUVBL2.
DR   HPA; ENSG00000183207; Low tissue specificity.
DR   MalaCards; RUVBL2; -.
DR   MIM; 604788; gene.
DR   OpenTargets; ENSG00000183207; -.
DR   VEuPathDB; HostDB:ENSG00000183207; -.
DR   eggNOG; KOG2680; Eukaryota.
DR   GeneTree; ENSGT00940000153556; -.
DR   HOGENOM; CLU_028311_4_0_1; -.
DR   InParanoid; Q9Y230; -.
DR   OMA; IINTEPY; -.
DR   OrthoDB; 10060499at2759; -.
DR   PAN-GO; Q9Y230; 9 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9Y230; -.
DR   PathwayCommons; Q9Y230; -.
DR   Reactome; R-HSA-171319; Telomere Extension By Telomerase.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SignaLink; Q9Y230; -.
DR   SIGNOR; Q9Y230; -.
DR   Agora; ENSG00000183207; -.
DR   BioGRID-ORCS; 10856; 842 hits in 1140 CRISPR screens.
DR   CD-CODE; 6F24707C; Cajal body.
DR   CD-CODE; 804901D1; Nuclear speckle.
DR   CD-CODE; 8C2F96ED; Centrosome.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   ChiTaRS; RUVBL2; human.
DR   EvolutionaryTrace; Q9Y230; -.
DR   GeneWiki; RUVBL2; -.
DR   GenomeRNAi; 10856; -.
DR   Pharos; Q9Y230; Tbio.
DR   PRO; PR:Q9Y230; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9Y230; protein.
DR   Bgee; ENSG00000183207; Expressed in left testis and 202 other cell types or tissues.
DR   ExpressionAtlas; Q9Y230; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0036064; C:ciliary basal body; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0120293; C:dynein axonemal particle; ISS:UniProtKB.
DR   GO; GO:0000791; C:euchromatin; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031011; C:Ino80 complex; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0071339; C:MLL1 complex; IDA:UniProtKB.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000786; C:nucleosome; IDA:ComplexPortal.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0101031; C:protein folding chaperone complex; IPI:ComplexPortal.
DR   GO; GO:0097255; C:R2TP complex; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IEA:Ensembl.
DR   GO; GO:1990062; C:RPAP3/R2TP/prefoldin-like complex; IPI:ComplexPortal.
DR   GO; GO:0000812; C:Swr1 complex; IDA:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IEA:Ensembl.
DR   GO; GO:0008013; F:beta-catenin binding; IDA:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:UniProtKB.
DR   GO; GO:0003678; F:DNA helicase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0140585; F:promoter-enhancer loop anchoring activity; IMP:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0017025; F:TBP-class protein binding; IDA:UniProtKB.
DR   GO; GO:0001094; F:TFIID-class transcription factor complex binding; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0000492; P:box C/D snoRNP assembly; IBA:GO_Central.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IMP:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IMP:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; IDA:ComplexPortal.
DR   GO; GO:0006310; P:DNA recombination; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0071169; P:establishment of protein localization to chromatin; IMP:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045739; P:positive regulation of DNA repair; ISO:ComplexPortal.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:ComplexPortal.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; IDA:ComplexPortal.
DR   GO; GO:1904507; P:positive regulation of telomere maintenance in response to DNA damage; ISO:ComplexPortal.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   GO; GO:0050821; P:protein stabilization; NAS:ComplexPortal.
DR   GO; GO:0042981; P:regulation of apoptotic process; NAS:ComplexPortal.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:ComplexPortal.
DR   GO; GO:0033044; P:regulation of chromosome organization; IMP:ComplexPortal.
DR   GO; GO:0006282; P:regulation of DNA repair; ISO:ComplexPortal.
DR   GO; GO:0006275; P:regulation of DNA replication; IMP:ComplexPortal.
DR   GO; GO:0060382; P:regulation of DNA strand elongation; IMP:ComplexPortal.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; NAS:ComplexPortal.
DR   GO; GO:2000779; P:regulation of double-strand break repair; NAS:ComplexPortal.
DR   GO; GO:0045995; P:regulation of embryonic development; ISO:ComplexPortal.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0090671; P:telomerase RNA localization to Cajal body; HMP:BHF-UCL.
DR   GO; GO:0000723; P:telomere maintenance; ISO:ComplexPortal.
DR   FunFam; 3.40.50.300:FF:002221; RuvB-like 2; 2.
DR   FunFam; 1.10.8.60:FF:000010; RuvB-like helicase; 1.
DR   FunFam; 2.40.50.360:FF:000002; RuvB-like helicase; 1.
DR   Gene3D; 1.10.8.60; -; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 2.40.50.360; RuvB-like helicase, domain II; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR027238; RuvB-like.
DR   InterPro; IPR041048; RuvB-like_C.
DR   InterPro; IPR042487; RuvBL1/2_DNA/RNA_bd_dom.
DR   InterPro; IPR010339; TIP49_P-loop.
DR   PANTHER; PTHR11093; RUVB-RELATED REPTIN AND PONTIN; 1.
DR   Pfam; PF06068; TIP49; 1.
DR   Pfam; PF17856; TIP49_C; 1.
DR   PRINTS; PR01874; DNAREPAIRADA.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing; ATP-binding;
KW   Chromatin regulator; Cytoplasm; Direct protein sequencing; DNA damage;
KW   DNA recombination; DNA repair; Growth regulation; Helicase; Hydrolase;
KW   Isopeptide bond; Membrane; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12665801, ECO:0000269|Ref.14,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:22814378,
FT                   ECO:0007744|PubMed:25944712"
FT   CHAIN           2..463
FT                   /note="RuvB-like 2"
FT                   /id="PRO_0000165644"
FT   BINDING         77..84
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.14, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   MOD_RES         437
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        9
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        444
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        456
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..45
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056584"
FT   MUTAGEN         83
FT                   /note="K->M: No effect on interaction with NOPCHAP1."
FT                   /evidence="ECO:0000269|PubMed:33367824"
FT   MUTAGEN         299
FT                   /note="D->N: Abolishes ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:17157868"
FT   MUTAGEN         300
FT                   /note="E->Q: Reduces ATPase activity. Decreases interaction
FT                   with NOPCHAP1. No effect on formation of RUVBL1-RUVBL2
FT                   heteromeric complex."
FT                   /evidence="ECO:0000269|PubMed:33205750,
FT                   ECO:0000269|PubMed:33367824"
FT   CONFLICT        214
FT                   /note="D -> N (in Ref. 6; AAD34041)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257..258
FT                   /note="FL -> YV (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   TURN            19..22
FT                   /evidence="ECO:0007829|PDB:3UK6"
FT   TURN            24..27
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   STRAND          41..43
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          45..48
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           50..64
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   TURN            66..70
FT                   /evidence="ECO:0007829|PDB:6H7X"
FT   STRAND          72..76
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           83..92
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          96..98
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          100..104
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           105..107
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           117..125
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          127..130
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          132..138
FT                   /evidence="ECO:0007829|PDB:7OLE"
FT   STRAND          147..149
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   STRAND          152..156
FT                   /evidence="ECO:0007829|PDB:2CQA"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   STRAND          162..165
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   STRAND          168..171
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   HELIX           179..183
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   STRAND          191..194
FT                   /evidence="ECO:0007829|PDB:6H7X"
FT   TURN            197..199
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   STRAND          205..207
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   STRAND          209..211
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   TURN            212..214
FT                   /evidence="ECO:0007829|PDB:8XVT"
FT   STRAND          216..218
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   STRAND          232..239
FT                   /evidence="ECO:0007829|PDB:7OLE"
FT   STRAND          241..243
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           244..250
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          251..254
FT                   /evidence="ECO:0007829|PDB:8XVT"
FT   HELIX           256..258
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   HELIX           259..262
FT                   /evidence="ECO:0007829|PDB:9C57"
FT   HELIX           270..286
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          290..293
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          295..299
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   TURN            300..302
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           306..316
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          318..320
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          323..329
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          331..334
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          341..343
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           348..351
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          354..358
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           364..375
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   TURN            376..379
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           384..396
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           399..415
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   STRAND          419..421
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           424..432
FT                   /evidence="ECO:0007829|PDB:6K0R"
FT   HELIX           436..449
FT                   /evidence="ECO:0007829|PDB:6K0R"
SQ   SEQUENCE   463 AA;  51157 MW;  54C78E9C587D975A CRC64;
     MATVTATTKV PEIRDVTRIE RIGAHSHIRG LGLDDALEPR QASQGMVGQL AARRAAGVVL
     EMIREGKIAG RAVLIAGQPG TGKTAIAMGM AQALGPDTPF TAIAGSEIFS LEMSKTEALT
     QAFRRSIGVR IKEETEIIEG EVVEIQIDRP ATGTGSKVGK LTLKTTEMET IYDLGTKMIE
     SLTKDKVQAG DVITIDKATG KISKLGRSFT RARDYDAMGS QTKFVQCPDG ELQKRKEVVH
     TVSLHEIDVI NSRTQGFLAL FSGDTGEIKS EVREQINAKV AEWREEGKAE IIPGVLFIDE
     VHMLDIESFS FLNRALESDM APVLIMATNR GITRIRGTSY QSPHGIPIDL LDRLLIVSTT
     PYSEKDTKQI LRIRCEEEDV EMSEDAYTVL TRIGLETSLR YAIQLITAAS LVCRKRKGTE
     VQVDDIKRVY SLFLDESRST QYMKEYQDAF LFNELKGETM DTS
//
